GlassScriptPhysician profile
David I Rabinowitz
NPI 1205226164
$502.59
in general payments reported to CMS, 2019-2025
7 companies · $271 in 2025
The $271 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.25 · 2022: $23.24 · 2023: $191 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $160.44 | 2023 | Signia |
| Madrigal Pharmaceuticals | $146.33 | 2025 | Rezdiffra |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Si-Bone, INC. | $23.24 | 2022 | |
| Merck Sharp & Dohme LLC | $17.25 | 2021 | |
| Apollo Endosurgery US INC | $16.81 | 2023 | Overstitch Endoscopic Suturing System |
| Heron Therapeutics, INC. | $13.52 | 2023 | Aponvie |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rabinowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.